Literature DB >> 29934802

ISCEV extended protocol for the photopic On-Off ERG.

Maja Sustar1, Graham E Holder2,3,4,5, Jan Kremers6, Claire S Barnes7, Bo Lei8, Naheed W Khan9, Anthony G Robson10,11.   

Abstract

The International Society for Clinical Electrophysiology of Vision (ISCEV) standard for full-field electroretinography (ERG) describes a minimum procedure, but encourages more extensive testing. This ISCEV extended protocol describes an extension to the ERG standard, namely the photopic On-Off ERG, and outlines common clinical applications. A light stimulus duration of 150-200 ms is used in the presence of a rod-suppressing background to elicit cone-driven On- and Off-system ERG components. The On-response occurs after the stimulus onset and has a negative a-wave and positive b-wave. The Off d-wave is a positive component evoked by stimulus offset. Common diagnoses that may benefit from additional photopic On-Off ERG testing include retinal dystrophies and retinal disorders that cause dysfunction at a level that is post-phototransduction or post-receptoral. On-Off ERGs assess the relative involvement of On- and Off-systems and may be of use in the diagnosis of disorders such as complete and incomplete congenital stationary night blindness (complete and incomplete CSNB), melanoma-associated retinopathy, and some forms of autoimmune retinopathy. The photopic On-Off ERGs may also be useful in X-linked retinoschisis, Batten disease, Duchenne muscular dystrophy, spinocerebellar degeneration, quinine toxicity, and other retinal disorders.

Entities:  

Keywords:  Bipolar cells; Clinical standards; Electroretinogram (ERG); Full-field ERG; International Society of Clinical Electrophysiology of Vision (ISCEV); Long-duration ERG; On–Off ERG; Retinal dystrophy; Retinopathy

Mesh:

Year:  2018        PMID: 29934802      PMCID: PMC6061123          DOI: 10.1007/s10633-018-9645-y

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


Introduction

The International Society for Clinical Electrophysiology of Vision (ISCEV) standard for full-field electroretinography (ERG) describes a minimum set of tests but encourages the use of additional ERG protocols for clinical ERG testing [1]. This extended protocol describes the photopic On–Off ERG, as a specialized procedure which is well established and broadly accepted by experts in the field. The protocol was prepared by the authors in accordance with ISCEV procedures http://www.iscev.org/standards/index.html), and was approved by the ISCEV Board of Directors on 25th March 2018.

Scope and applications

The standard light-adapted (LA) 3.0 ERG b-wave is evoked with flashes of a short duration (< 5 ms) on a rod-saturating background and largely reflects overlapping contributions from the On- and Off-bipolar cell pathways. Separation of the function of the On- and Off-pathways requires long-duration stimuli (e.g., 150–200 ms) in the presence of a rod-saturating background. The photopic On–Off ERG has two major components, the On-response and the Off-response. The On-response occurs after the stimulus onset and consists of two prominent waves, the negative polarity a-wave and the positive b-wave. The Off-response, or d-wave, is a positive polarity component in response to stimulus offset [2-4]. The sources of On- and Off-responses were elucidated by experimental pharmacological studies in non-human primates, whose ERGs are very similar to those in humans. These studies showed that the a-wave of the On-response originates from cone photoreceptors, with a significant contribution from Off- (hyperpolarizing) bipolar cells [5]. The b-wave of the On-response reflects the function of the On- (depolarizing) bipolar cells, although its amplitude and shape may be influenced by Off-bipolar and horizontal cells [6]. The d-wave is a complex response; the initial rapid phase originates from Off-bipolar cell activity, but cone photoreceptors contribute to the later slow phase and On-bipolar cells act in an opposite polarity direction [7, 8]. Common diagnoses that may benefit from additional photopic On–Off ERG testing include retinal dystrophies and retinal disorders that cause dysfunction post-phototransduction or at a post-receptoral level. The photopic On–Off ERG allows evaluation of the relative or selective involvement of On- and Off-pathways, not fully enabled by the standard LA 3.0 ERG responses [2–4, 9–15]. Common forms of congenital stationary night blindness (CSNB) are good illustrative examples. In complete CSNB, there is generalized On-bipolar cell dysfunction, and the waveform shows an electronegative On-response but a preserved Off-response. In contrast, incomplete CSNB is associated with abnormalities affecting both the On- and Off-responses [2]. Other retinal disorders associated with selective On-pathway dysfunction include melanoma-associated retinopathy, early cases of phosphomannomutase deficiency (PMM2-CDG) [12], and some forms of autoimmune retinopathy [15]. The photopic On–Off ERGs may also be useful in X-linked retinoschisis, Batten disease, Duchenne muscular dystrophy, spinocerebellar degeneration, quinine toxicity, and other disorders [16, 17].

Patient population

Patients of all ages able to tolerate Ganzfeld stimulation, referred for investigation of possible retinal dysfunction, especially those with decreased light-adapted and/or dark-adapted ERG b-wave and relatively preserved a-wave (electronegative ERG or low b:a ratio), suggesting dysfunction post-phototransduction or at the level of the bipolar cells.

Technical issues

The photopic On–Off ERG protocol will follow the specifications of the current ISCEV standard ERG [1]. Additional considerations include the following: (a) Stimulus duration. The duration of the light stimulus should be long enough to separate the On- and Off-responses. Most studies used durations of between 150 and 200 ms (Table 1 in appendix), based on the largest d-wave amplitude attained, although statistically, smaller amplitudes are reported only for flash durations shorter than 75 ms [18]. Further increase in the d-wave amplitude was observed with stimuli up to 900 ms duration [19], but responses to such long durations take longer to record. Patient comfort and minimizing possible eye closure and blink artefacts are considerations when selecting the light duration.
Table 1

Previously published recording parameters

ReferencesStimulus strengthBackground luminanceStimulus duration (ms)Stimulus and background wavelength
[4]185 cd m−243 cd m−2150White stimulus on white background
[3]3.7 log cd m−2 (5011 cd m−2)2.1 log cd m−2 (125 cd m−2)5–100White stimulus on white background
[9, 53]3 cd s m−2 (15 cd m−2)a10 cd m−2200 and 250Red and green stimulus on white background
[10]750 cd m−242 cd m−2500White stimulus on white background
[11]3 cd s m−2 (12 cd m−2)10 cd m−2256630 nm stimulus on white background
[12]200 cd m−243 cd m−290, 120White 6500K
[13]3 log cd s m−2 (5000 cd m−2)2 log cd m−2 (100 cd m−2)200White stimulus on white background
[14]398 cd m−248 cd m−2200White stimulus on white background
[21]0.6–3.5 log cd m−2 (4–3162 cd m−2)40 cd m−2250White stimulus on white background
[18, 56]0.4–2.1 log cd s m−2 (12.5–629 cd m−2)20-50 cd m−25–200White, 460, 508 and 667 nm stimulus on white background
[15, 17, 20, 38, 41, 52]560 cd m−2160 cd m−2150–200620 nm stimulus on 530 nm background
[35]440 cd m−2160 cd m−2200612 nm stimulus on 530 nm background
[36]133 cd m−243 cd m−2120White 6500K
[37]1.7 log cd s m−2 (250 cd m−2)40 cd m−2200White stimulus (6500K) on white background
[39]1 cd s/m2 (4 cd m−2)30 cd m−2250White 6500K
[40]200 cd m−242 cd m−2150White stimulus on white background
[42]4 log ph td (200 cd m−2)b3.3 log ph td (40 cd m−2)b150White stimulus on white background
[43]200 cd m−230 cd m−2100White stimulus on white background
[44]225 cd m−230 cd m−2188White stimulus on white background
[4548]300 cd m−240 cd m−2150White stimulus on white background
[49]650 cd m−2160 cd m−2120, 200Orange stimulus on green background
[50]200 cd m−242 cd m−2150White stimulus on white background
[51]1700 cd m−228 cd m−2125White stimulus on white background
[54]360 cd m−240 cd m−2100White stimulus on white background
[55, 57]1120 cd m−230 cd m−2200White stimulus on white background
[58]40,60,80 cd m−220 cd m−2240White stimulus on white background
[59]2.5 log cd m−2 (316 cd m−2)40 cd m−2150White stimulus on white background

aTime integrated luminance divided by the length of the stimulus in seconds

bCalculated for 8 mm pupil diameter

(b) Stimulus wavelength. The flash and background wavelength for the ISCEV standard ERG are defined as visibly white, with CIE coordinates near x = 0.31, y = 0.32. Both white and chromatic (blue and green) stimuli have been used to elicit On–Off ERGs of similar waveform [18]. Some laboratories use orange stimuli in the presence of green background, for more selective stimulation of L-and M-cone system with simultaneous suppression of the rods and S-cones [17, 20]. These stimuli are effective at eliciting On- and Off-responses and have been shown to be informative in numerous studies. Longer wavelength stimuli (red) may decrease the d-wave and change the shape of the b-wave [18, 19] and should be avoided. (c) Stimulus strength and background luminance. Brighter backgrounds require stronger stimuli to elicit detectable responses [18]. If stimuli are too weak, responses are small. If stimuli are too strong the b-wave becomes broader and peak time variable and difficult to determine [18], while the d-wave becomes either decreased or dominated by a component of longer peak time (the basis of the photopic hill phenomenon) [21]. Strong stimuli and backgrounds may also be poorly tolerated by some patients.

Calibration

The protocol is technically similar to that for the ISCEV standard ERG, and the calibration and frequency of calibration should follow the latest ISCEV standard [1]. The strength of the stimulus and background luminance should be specified in photopic candelas per meter squared (phot cd m−2).

Protocol specification

Patient preparation follows that for the current ISCEV standard ERG [1]. It is suggested that for routine applications the photopic On–Off ERG is added to the ISCEV standard protocol after the other LA ERGs. This extended protocol has the following additional specifications. (a) Stimulus duration. A stimulus duration of 150 ms or 200 ms. To allow clear separation of On- and Off- responses, efficient signal averaging and to maintain consistency with the majority of published clinical studies to date. (b) Stimulus wavelength. A white stimulus on a white background (as used in the majority of published studies) or a chromatic light on a chromatic background (to suppress rods and S-cones) may be used providing longer wavelength (red) stimuli are avoided. Orange (620 nm) stimuli in the presence of green (560 nm) background may allow more selective stimulation of L-and M-cone systems with simultaneous suppression of the rods and S-cones. (c) Stimulus strength and background luminance. Stimulus luminance for white stimuli is 250 cd m−2 or within the range phot 150–350 cd m−2 with a background luminance of 30 cd m−2. (d) Frequency of stimulus presentation. A stimulus rate of ≤ 2 per second (inter-stimulus interval ≥ 0.5 s), as for the current ISCEV Standard LA 3.0 ERG.

Response evaluation

The photopic On–Off ERG response consists of three prominent waves, the a- and b-waves as part of the On-response and the Off-response complex, mainly the d-wave (Fig. 1). A negative a-wave appears in response to the onset of the stimulus, followed by the positive-going On-response b-wave. The d-wave of the Off-response is the positive peak, which occurs after stimulus offset. The amplitude of the a-wave is measured from the baseline to the first negative trough. The amplitude of the b-wave is measured from the trough of the a-wave to the peak of the b-wave. The amplitude of the d-wave is measured from the time point of stimulus offset to the peak of the d-wave. Peak times of On-response components are measured from the beginning of the stimulus to the trough of the a-wave and peak of the b-wave; Off-response peak time is measured from stimulus offset to the peak of the d-wave. The amplitude and peak time values should be evaluated and compared with reference normative data, established in each laboratory for its own equipment, recording protocols and patient population.
Fig. 1

Diagram of the three main components of the photopic On–Off ERG and their measurement. Stimulus duration is indicated at the bottom of the figure; red (vertical) arrows indicate amplitude measurement, blue (horizontal) arrows indicate peak time measurement. Two traces are superimposed to demonstrate reproducibility

Diagram of the three main components of the photopic On–Off ERG and their measurement. Stimulus duration is indicated at the bottom of the figure; red (vertical) arrows indicate amplitude measurement, blue (horizontal) arrows indicate peak time measurement. Two traces are superimposed to demonstrate reproducibility

Reporting

This protocol is intended to be used for routine applications as an extension to the standard ERG protocol, and reporting should follow the latest ISCEV standard for ERG [1]. Additionally, the spectral characteristics of the stimulus and background should be acknowledged if different from the standard LA ERG (e.g., peak wavelength and bandwidth). The duration of the light stimulus should be stated and luminance (in phot cd m−2) of stimulus and background should be stated. Unless already embedded within the ISCEV standard ERG protocol, pupil size and duration of light adaption should be stated. The amplitude of the a-, b-, and d-waves and respective time to peaks may be reported along with age-appropriate laboratory reference normative data. It is acknowledged that in diagnostic studies involving ISCEV standard ERGs, it may be sufficiently informative to describe the relative involvement of On–Off ERG a-, b-, and d-waves qualitatively.
  59 in total

1.  On-response deficit in the electroretinogram of the cone system in X-linked retinoschisis.

Authors:  K R Alexander; G A Fishman; C S Barnes; S Grover
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-02       Impact factor: 4.799

2.  "On" response dysfunction in multifocal posterior pigment epitheliopathy.

Authors:  Masamoto Imaizumi; Celso Soiti Matsumoto; Ken-Ichi Kimoto; Masatoshi Furushima; Kazuo Nakatsuka
Journal:  Retina       Date:  2002-02       Impact factor: 4.256

3.  Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy.

Authors:  Kenneth R Alexander; Claire S Barnes; Gerald A Fishman; Ann H Milam
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

4.  The ERG of guinea pig (Cavis porcellus): comparison with I-type monkey and E-type rat.

Authors:  Bo Lei
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

5.  Night blindness and abnormal cone electroretinogram ON responses in patients with mutations in the GRM6 gene encoding mGluR6.

Authors:  Thaddeus P Dryja; Terri L McGee; Eliot L Berson; Gerald A Fishman; Michael A Sandberg; Kenneth R Alexander; Deborah J Derlacki; Aruna S Rajagopalan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

Review 6.  The negative ERG: clinical phenotypes and disease mechanisms of inner retinal dysfunction.

Authors:  Isabelle Audo; Anthony G Robson; Graham E Holder; Anthony T Moore
Journal:  Surv Ophthalmol       Date:  2008 Jan-Feb       Impact factor: 6.048

7.  Prph2 mutations as a cause of electronegative ERG.

Authors:  Rola Ba-Abbad; Anthony G Robson; Yew C Yap; Anthony T Moore; Andrew R Webster; Graham E Holder
Journal:  Retina       Date:  2014-06       Impact factor: 4.256

8.  Severe course of cutaneous melanoma associated paraneoplastic retinopathy.

Authors:  U Kellner; N Bornfeld; M H Foerster
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

9.  Primate Retinal Signaling Pathways: Suppressing ON-Pathway Activity in Monkey With Glutamate Analogues Mimics Human CSNB1-NYX Genetic Night Blindness.

Authors:  Naheed W Khan; Mineo Kondo; Kelaginamane T Hiriyanna; Jeff A Jamison; Ronald A Bush; Paul A Sieving
Journal:  J Neurophysiol       Date:  2004-08-25       Impact factor: 2.714

10.  Three cone mechanisms in the primate electroretinogram: two with, one without off-center bipolar responses.

Authors:  H U Evers; P Gouras
Journal:  Vision Res       Date:  1986       Impact factor: 1.886

View more
  19 in total

1.  ISCEV extended protocol for the stimulus-response series for light-adapted full-field ERG.

Authors:  Daphne L McCulloch; Mineo Kondo; Ruth Hamilton; Pierre Lachapelle; André M V Messias; Anthony G Robson; Shinji Ueno
Journal:  Doc Ophthalmol       Date:  2019-03-30       Impact factor: 2.379

2.  Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.

Authors:  Eleni Karatsai; Anthony G Robson; Simon R J Taylor
Journal:  JAMA Ophthalmol       Date:  2019-05-01       Impact factor: 7.389

3.  Use of extended protocols with nonstandard stimuli to characterize rod and cone contributions to the canine electroretinogram.

Authors:  Nate Pasmanter; Laurence M Occelli; András M Komáromy; Simon M Petersen-Jones
Journal:  Doc Ophthalmol       Date:  2022-03-05       Impact factor: 2.379

4.  Melanoma-associated retinopathy with anti-TRPM1 autoantibodies showing concomitant Off-bipolar cell dysfunction.

Authors:  Wei-Che Hung; Hui-Chen Cheng; An-Guor Wang
Journal:  Doc Ophthalmol       Date:  2022-09-29       Impact factor: 1.854

5.  Asymmetric Functional Impairment of ON and OFF Retinal Pathways in Glaucoma.

Authors:  Alan W Kong; Marcus L Turner; Hoover Chan; Robert L Stamper; Benjamin F Arnold; Luca Della Santina; Yvonne Ou
Journal:  Ophthalmol Sci       Date:  2021-05-10

Review 6.  VEP estimation of visual acuity: a systematic review.

Authors:  Ruth Hamilton; Michael Bach; Sven P Heinrich; Michael B Hoffmann; J Vernon Odom; Daphne L McCulloch; Dorothy A Thompson
Journal:  Doc Ophthalmol       Date:  2020-06-02       Impact factor: 2.379

7.  KCNV2-Associated Retinopathy: Genetics, Electrophysiology, and Clinical Course-KCNV2 Study Group Report 1.

Authors:  Michalis Georgiou; Anthony G Robson; Kaoru Fujinami; Shaun M Leo; Ajoy Vincent; Fadi Nasser; Thales Antônio Cabral De Guimarães; Samer Khateb; Nikolas Pontikos; Yu Fujinami-Yokokawa; Xiao Liu; Kazushige Tsunoda; Takaaki Hayashi; Mauricio E Vargas; Alberta A H J Thiadens; Emanuel R de Carvalho; Xuan-Thanh-An Nguyen; Gavin Arno; Omar A Mahroo; Maria Inmaculada Martin-Merida; Belen Jimenez-Rolando; Gema Gordo; Ester Carreño; Ayuso Carmen; Dror Sharon; Susanne Kohl; Rachel M Huckfeldt; Bernd Wissinger; Camiel J F Boon; Eyal Banin; Mark E Pennesi; Arif O Khan; Andrew R Webster; Eberhart Zrenner; Elise Héon; Michel Michaelides
Journal:  Am J Ophthalmol       Date:  2020-12-11       Impact factor: 5.258

8.  SSBP1 mutations in dominant optic atrophy with variable retinal degeneration.

Authors:  Neringa Jurkute; Costin Leu; Hans-Martin Pogoda; Gavin Arno; Anthony G Robson; Gudrun Nürnberg; Janine Altmüller; Holger Thiele; Susanne Motameny; Mohammad Reza Toliat; Kate Powell; Wolfgang Höhne; Michel Michaelides; Andrew R Webster; Anthony T Moore; Matthias Hammerschmidt; Peter Nürnberg; Patrick Yu-Wai-Man; Marcela Votruba
Journal:  Ann Neurol       Date:  2019-07-31       Impact factor: 11.274

Review 9.  Probing ON and OFF Retinal Pathways in Glaucoma Using Electroretinography.

Authors:  Alan W Kong; Luca Della Santina; Yvonne Ou
Journal:  Transl Vis Sci Technol       Date:  2020-10-14       Impact factor: 3.283

10.  A genetic and clinical study of individuals with nonsyndromic retinopathy consequent upon sequence variants in HGSNAT, the gene associated with Sanfilippo C mucopolysaccharidosis.

Authors:  Elena R Schiff; Malena Daich Varela; Anthony G Robson; Karen Pierpoint; Rola Ba-Abbad; Savita Nutan; Wadih M Zein; Ehsan Ullah; Laryssa A Huryn; Sari Tuupanen; Omar A Mahroo; Michel Michaelides; Derek Burke; Katie Harvey; Gavin Arno; Robert B Hufnagel; Andrew R Webster
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-08-07       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.